Project Grant HT94252310796

Award Date 8/1/23
Completion Date 7/31/26
Dollars Obligated $472K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
Oregon Health & Science University was awarded a $385,000 project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The two-year grant will support research to investigate the molecular and biological contributions of the SMARCA4 tumor suppressor gene to the formation of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). Through basic and applied medical research, the Military Medical Research and Development...
Oregon Health & Science University was awarded a $494,340 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
Oregon Health & Science University was awarded a $506,554 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. Through basic, applied, and advanced biomedical research supported by this program, the Army aims to transform military and public health care by...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $999,823 Project Grant to Oregon Health & Science University (OHSU) on June 1, 2024. The grant, titled "TARGETING NEURODEGENERATION IN THE AGED DEMYELINATED CNS," supports OHSU's biomedical research efforts to investigate innovative treatments for neurological disorders. Through this funding, OHSU will conduct basic, applied, and advanced research to develop new medical...
This Project Grant award of $1,401,794.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The funding will support a 3-year research project investigating the impact of recent childbirth on breast cancer prognosis and tumor molecular phenotypes among young Black and White women. The research aims to enhance understanding of breast cancer disease progression and outcomes in this...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Project Grant award for $897,448.00, awarded on June 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports Oregon Health & Science University's development of "NEXT-GENERATION ELQS FOR LONG-TERM PROTECTION AGAINST MALARIA." This research initiative aims to advance novel treatments and protective measures against malaria, a key focus area for the Defense Health Agency's military medical research initiatives....
This federal Project Grant award of $1,525,292 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project led by Oregon Health & Science University (OHSU) to characterize the progression of prostate cancer through integrated analysis of single-cell data. The project, which commenced on September 30, 2024 and is scheduled for completion by September 29, 2027, aims to advance the understanding of prostate cancer biology and...
This Project Grant award of $395,134.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), will fund a collaborative pilot project between Oregon Health & Science University (OHSU) and the Warm Springs Tribe to address health disparities in the Native American population. The project aims to transform healthcare for military service members and the broader public through innovative biomedical research focused...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...

The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these rare and difficult-to-treat tumor types. The funding will support OHSU's efforts to advance medical solutions that can improve healthcare for U.S. military service members and the broader public.

Generated 4/23/24, 6:15 AM